EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Imidazo[1,2‐ a ]Pyridine Derivatives as Promising Anticancer Agents: Synthesis and Therapeutic Potential

Drashti Shah, Ashish Patel

Archiv der Pharmazie · 2026-02 · 359 (2)

DOI: 10.1002/ardp.70214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 23.02.2026. Verfasst von Drashti Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyridines, Neoplasms, Imidazoles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterocyclic compounds play a crucial role in medicinal chemistry, with imidazo[1,2‐ a ]pyridine emerging as a significant scaffold due to its broad pharmacological applications. The unique structural framework of imidazo[1,2‐ a ]pyridine allows for strong interactions with biological targets, making it a favorable candidate for anticancer drug development. This review explores the recent advancements in the synthesis, structure–activity relationship (SAR), and mechanistic insights of imidazo[1,2‐ a ]pyridine derivatives as anticancer agents. Various synthetic methodologies, including multicomponent reactions and named transformations, have facilitated the generation of diverse derivatives with potent biological activity. The anticancer properties of these compounds stem from their ability to modulate key signaling pathways, induce apoptosis, and inhibit kinases implicated in tumor progression. Additionally, we discuss cytotoxic evaluations and the therapeutic potential of these derivatives against different cancer cell lines. The review highlights the challenges and future perspectives in optimizing imidazo[1,2‐ a ]pyridine‐based compounds for clinical applications, emphasizing their promise as next‐generation anticancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPyridinesNeoplasmsImidazolesHumansStructure-Activity RelationshipAnimalsMolecular StructureApoptosisSignal TransductionProtein Kinase Inhibitors

Stichwörter der Autor:innen

anticancer agentsimidazo[1,2‐a]pyridinekinase inhibitionstructure–activity relationshipsynthetic methodologies

Substanzen

Antineoplastic AgentsPyridinesImidazolesimidazo(1,2-a)pyridineProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India.

Zitieren

APA

Shah, D., & Patel, A. (2026). Imidazo[1,2‐ a ]Pyridine Derivatives as Promising Anticancer Agents: Synthesis and Therapeutic Potential. Archiv der Pharmazie, 359(2). https://doi.org/10.1002/ardp.70214

Vancouver

Shah D, Patel A. Imidazo[1,2‐ a ]Pyridine Derivatives as Promising Anticancer Agents: Synthesis and Therapeutic Potential. Archiv der Pharmazie. 2026;359(2). doi:10.1002/ardp.70214

BibTeX
@article{Shah2026,
  author = {Shah, Drashti and Patel, Ashish},
  title = {Imidazo[1,2‐ a ]Pyridine Derivatives as Promising Anticancer Agents: Synthesis and Therapeutic Potential},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {2},
  doi = {10.1002/ardp.70214}
}
Kostenlos starten →